<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p196" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_196{left:35px;bottom:24px;letter-spacing:-0.34px;word-spacing:0.13px;}
#t2_196{left:306px;bottom:30px;}
#t3_196{left:313px;bottom:24px;letter-spacing:0.16px;}
#t4_196{left:346px;bottom:30px;}
#t5_196{left:351px;bottom:24px;letter-spacing:-0.16px;word-spacing:-0.22px;}
#t6_196{left:517px;bottom:30px;}
#t7_196{left:524px;bottom:24px;letter-spacing:-0.28px;word-spacing:-0.09px;}
#t8_196{left:288px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t9_196{left:288px;bottom:829px;letter-spacing:0.27px;word-spacing:-0.69px;}
#ta_196{left:1115px;bottom:27px;letter-spacing:0.23px;}
#tb_196{left:35px;bottom:777px;letter-spacing:0.13px;word-spacing:0.06px;}
#tc_196{left:35px;bottom:754px;letter-spacing:0.09px;word-spacing:0.1px;}
#td_196{left:35px;bottom:731px;letter-spacing:0.03px;word-spacing:0.3px;}
#te_196{left:35px;bottom:707px;letter-spacing:-0.13px;}
#tf_196{left:99px;bottom:715px;letter-spacing:0.1px;}
#tg_196{left:35px;bottom:667px;letter-spacing:0.01px;word-spacing:-0.44px;}
#th_196{left:35px;bottom:645px;letter-spacing:0.07px;word-spacing:0.11px;}
#ti_196{left:35px;bottom:622px;letter-spacing:0.1px;word-spacing:-0.84px;}
#tj_196{left:299px;bottom:622px;letter-spacing:0.06px;word-spacing:-1.11px;}
#tk_196{left:414px;bottom:622px;letter-spacing:-0.08px;word-spacing:-0.96px;}
#tl_196{left:35px;bottom:599px;letter-spacing:0.06px;word-spacing:0.13px;}
#tm_196{left:35px;bottom:575px;letter-spacing:0.2px;word-spacing:-0.01px;}
#tn_196{left:512px;bottom:583px;letter-spacing:0.06px;}
#to_196{left:35px;bottom:552px;letter-spacing:0.04px;word-spacing:-0.19px;}
#tp_196{left:35px;bottom:529px;letter-spacing:0.15px;word-spacing:0.04px;}
#tq_196{left:35px;bottom:506px;letter-spacing:0.02px;word-spacing:-0.91px;}
#tr_196{left:35px;bottom:482px;letter-spacing:0.08px;word-spacing:0.11px;}
#ts_196{left:35px;bottom:459px;letter-spacing:0.16px;}
#tt_196{left:132px;bottom:467px;letter-spacing:0.1px;}
#tu_196{left:35px;bottom:419px;letter-spacing:0.04px;word-spacing:0.15px;}
#tv_196{left:35px;bottom:396px;letter-spacing:0.08px;word-spacing:-0.1px;}
#tw_196{left:35px;bottom:372px;letter-spacing:0.09px;word-spacing:-0.73px;}
#tx_196{left:35px;bottom:349px;letter-spacing:0.12px;word-spacing:0.07px;}
#ty_196{left:35px;bottom:326px;letter-spacing:0.12px;word-spacing:0.07px;}
#tz_196{left:35px;bottom:303px;letter-spacing:0.03px;word-spacing:-0.46px;}
#t10_196{left:35px;bottom:280px;letter-spacing:-0.01px;word-spacing:0.19px;}
#t11_196{left:35px;bottom:256px;letter-spacing:0.22px;word-spacing:-0.03px;}
#t12_196{left:35px;bottom:233px;letter-spacing:0.13px;word-spacing:0.06px;}
#t13_196{left:35px;bottom:210px;letter-spacing:0.05px;word-spacing:0.13px;}
#t14_196{left:35px;bottom:171px;letter-spacing:0.2px;}
#t15_196{left:35px;bottom:141px;letter-spacing:0.1px;word-spacing:0.09px;}
#t16_196{left:35px;bottom:118px;letter-spacing:0.07px;word-spacing:0.12px;}
#t17_196{left:35px;bottom:95px;letter-spacing:0.16px;word-spacing:0.02px;}
#t18_196{left:154px;bottom:95px;letter-spacing:0.12px;word-spacing:0.07px;}
#t19_196{left:35px;bottom:72px;letter-spacing:0.05px;word-spacing:0.13px;}
#t1a_196{left:618px;bottom:777px;letter-spacing:0.15px;word-spacing:0.18px;}
#t1b_196{left:618px;bottom:754px;letter-spacing:0.13px;word-spacing:0.06px;}
#t1c_196{left:618px;bottom:731px;letter-spacing:0.13px;word-spacing:0.07px;}
#t1d_196{left:618px;bottom:707px;letter-spacing:0.23px;word-spacing:-0.05px;}
#t1e_196{left:743px;bottom:707px;letter-spacing:0.16px;word-spacing:0.02px;}
#t1f_196{left:862px;bottom:707px;letter-spacing:0.13px;word-spacing:0.06px;}
#t1g_196{left:618px;bottom:684px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1h_196{left:618px;bottom:645px;letter-spacing:0.18px;word-spacing:-0.86px;}
#t1i_196{left:618px;bottom:622px;letter-spacing:0.02px;word-spacing:0.17px;}
#t1j_196{left:618px;bottom:599px;letter-spacing:0.06px;word-spacing:0.13px;}
#t1k_196{left:618px;bottom:575px;letter-spacing:0.12px;word-spacing:0.07px;}
#t1l_196{left:618px;bottom:552px;letter-spacing:0.06px;word-spacing:0.26px;}
#t1m_196{left:618px;bottom:529px;letter-spacing:0.12px;word-spacing:0.09px;}
#t1n_196{left:618px;bottom:506px;letter-spacing:0.12px;word-spacing:-0.31px;}
#t1o_196{left:618px;bottom:482px;letter-spacing:0.1px;word-spacing:0.08px;}
#t1p_196{left:618px;bottom:459px;letter-spacing:0.06px;word-spacing:0.13px;}
#t1q_196{left:618px;bottom:436px;letter-spacing:0.01px;word-spacing:0.17px;}
#t1r_196{left:1150px;bottom:444px;letter-spacing:-0.01px;}
#t1s_196{left:618px;bottom:413px;word-spacing:0.19px;}
#t1t_196{left:618px;bottom:390px;word-spacing:0.18px;}
#t1u_196{left:618px;bottom:366px;letter-spacing:0.16px;word-spacing:0.03px;}
#t1v_196{left:618px;bottom:343px;letter-spacing:0.13px;word-spacing:0.06px;}
#t1w_196{left:618px;bottom:320px;letter-spacing:0.08px;word-spacing:-0.16px;}
#t1x_196{left:618px;bottom:297px;letter-spacing:0.13px;word-spacing:0.06px;}
#t1y_196{left:618px;bottom:273px;letter-spacing:0.1px;word-spacing:0.08px;}
#t1z_196{left:618px;bottom:250px;letter-spacing:0.06px;word-spacing:0.13px;}
#t20_196{left:1025px;bottom:250px;letter-spacing:0.23px;word-spacing:-0.05px;}
#t21_196{left:618px;bottom:227px;letter-spacing:0.2px;word-spacing:0.02px;}
#t22_196{left:875px;bottom:227px;letter-spacing:0.12px;word-spacing:0.07px;}
#t23_196{left:618px;bottom:204px;letter-spacing:0.09px;word-spacing:0.1px;}
#t24_196{left:737px;bottom:211px;letter-spacing:-0.01px;}
#t25_196{left:618px;bottom:163px;letter-spacing:0.03px;word-spacing:0.15px;}
#t26_196{left:618px;bottom:140px;letter-spacing:0.07px;word-spacing:0.12px;}
#t27_196{left:618px;bottom:117px;letter-spacing:0.12px;word-spacing:0.07px;}
#t28_196{left:618px;bottom:94px;letter-spacing:0.11px;word-spacing:0.09px;}
#t29_196{left:618px;bottom:71px;letter-spacing:0.11px;word-spacing:0.07px;}
#t2a_196{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_196{font-size:10px;font-family:ArialMT_5tg;color:#000;}
.s1_196{font-size:6px;font-family:ArialMT_5tg;color:#000;}
.s2_196{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_196{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_196{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s5_196{font-size:11px;font-family:ArialMT_5tg;color:#000;}
.s6_196{font-size:17px;font-family:Arial-ItalicMT_kb;color:#000;}
.s7_196{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts196" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-ItalicMT_kb;
	src: url("fonts/Arial-ItalicMT_kb.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg196Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg196" style="-webkit-user-select: none;"><object width="1210" height="935" data="196/196.svg" type="image/svg+xml" id="pdf196" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_196" class="t s0_196">Version 4.2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_196" class="t s1_196">© </span>
<span id="t3_196" class="t s0_196">(NCCN </span>
<span id="t4_196" class="t s1_196">© </span>
<span id="t5_196" class="t s0_196">), All rights reserved. NCCN Guidelines </span>
<span id="t6_196" class="t s1_196">® </span>
<span id="t7_196" class="t s0_196">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_196" class="t s2_196">NCCN Guidelines Version 4.2024 </span>
<span id="t9_196" class="t s2_196">Head and Neck Cancers </span>
<span id="ta_196" class="t s3_196">MS-55 </span>
<span id="tb_196" class="t s4_196">sites. These patients require dedicated imaging of the H&amp;N. This can be </span>
<span id="tc_196" class="t s4_196">accomplished through contrast-enhanced CT imaging. An FDG-PET/CT </span>
<span id="td_196" class="t s4_196">may reveal a primary site not visible on contrast-enhanced CT </span>
<span id="te_196" class="t s4_196">imaging. </span>
<span id="tf_196" class="t s5_196">678,679 </span>
<span id="tg_196" class="t s4_196">When a needle biopsy shows squamous cell carcinoma, adenocarcinoma, </span>
<span id="th_196" class="t s4_196">or anaplastic/undifferentiated epithelial cancer without a primary site, </span>
<span id="ti_196" class="t s4_196">additional studies are needed (see </span><span id="tj_196" class="t s6_196">Occult Primary </span><span id="tk_196" class="t s4_196">in the NCCN Guidelines </span>
<span id="tl_196" class="t s4_196">for Head and Neck Cancers). High-risk HPV and EBV testing are </span>
<span id="tm_196" class="t s4_196">recommended for squamous cell or undifferentiated histology. </span>
<span id="tn_196" class="t s5_196">550,680-684 </span>
<span id="to_196" class="t s4_196">High-risk HPV and EBV testing can be useful in workup and management </span>
<span id="tp_196" class="t s4_196">of cancers of the neck of unknown primary, and patients with EBV- or </span>
<span id="tq_196" class="t s4_196">HPV-related cervical adenopathy are staged according to the classification </span>
<span id="tr_196" class="t s4_196">for nasopharyngeal and HPV-positive oropharyngeal cancer, </span>
<span id="ts_196" class="t s4_196">respectively. </span>
<span id="tt_196" class="t s5_196">685,686 </span>
<span id="tu_196" class="t s4_196">A thorough operative examination of at-risk mucosal sites is an important </span>
<span id="tv_196" class="t s4_196">component in the workup of a patient with an occult primary, especially in </span>
<span id="tw_196" class="t s4_196">scenarios where CT or PET imaging do not reveal the primary site. During </span>
<span id="tx_196" class="t s4_196">this procedure, directed biopsies of areas of mucosal abnormalities </span>
<span id="ty_196" class="t s4_196">suspicious for the primary site are undertaken. Randomly directed </span>
<span id="tz_196" class="t s4_196">biopsies of normal-appearing mucosa in potential primary sites have a low </span>
<span id="t10_196" class="t s4_196">yield and seldom disclose a primary cancer. Many primary cancers are </span>
<span id="t11_196" class="t s4_196">identified after tonsillectomy. However, the therapeutic benefit of this </span>
<span id="t12_196" class="t s4_196">surgery is uncertain because, when patients have been treated without </span>
<span id="t13_196" class="t s4_196">tonsillectomy, only a few develop a clinically significant primary tumor. </span>
<span id="t14_196" class="t s3_196">Treatment </span>
<span id="t15_196" class="t s4_196">Neck dissection is recommended for all patients with </span>
<span id="t16_196" class="t s4_196">thyroglobulin-negative and calcitonin-negative adenocarcinoma (see </span>
<span id="t17_196" class="t s6_196">Occult Primary </span><span id="t18_196" class="t s4_196">in the NCCN Guidelines for Head and Neck Cancers). If </span>
<span id="t19_196" class="t s4_196">the metastatic adenocarcinoma presents high in the neck, parotidectomy </span>
<span id="t1a_196" class="t s4_196">may be included with the neck dissection. After neck dissection, </span>
<span id="t1b_196" class="t s4_196">management depends on the findings (ie, N1 without extranodal </span>
<span id="t1c_196" class="t s4_196">extension, N2 or N3 without extranodal extension, or extranodal </span>
<span id="t1d_196" class="t s4_196">extension) (see </span><span id="t1e_196" class="t s6_196">Occult Primary </span><span id="t1f_196" class="t s4_196">in the NCCN Guidelines for Head and </span>
<span id="t1g_196" class="t s4_196">Neck Cancers). </span>
<span id="t1h_196" class="t s4_196">Due to the infrequency of this disease, high-level prospective evidence to </span>
<span id="t1i_196" class="t s4_196">guide clinical management is lacking. Among NCCN Member Institutions, </span>
<span id="t1j_196" class="t s4_196">significant variation exists regarding the management of squamous cell </span>
<span id="t1k_196" class="t s4_196">carcinoma, poorly differentiated or nonkeratinizing squamous cell </span>
<span id="t1l_196" class="t s4_196">carcinoma, anaplastic cancer (not thyroid) of unknown primary site, or </span>
<span id="t1m_196" class="t s4_196">other uncommon histologies. The panel members believe such patients </span>
<span id="t1n_196" class="t s4_196">should be treated with a neck dissection. RT is also an option for patients </span>
<span id="t1o_196" class="t s4_196">with N1 disease, as a retrospective single-institution study showed that </span>
<span id="t1p_196" class="t s4_196">IMRT in patients with cervical lymph node metastasis from an unknown </span>
<span id="t1q_196" class="t s4_196">primary was associated with good local control and survival outcomes. </span>
<span id="t1r_196" class="t s5_196">687 </span>
<span id="t1s_196" class="t s4_196">Among N2–3 squamous cell carcinomas with occult primary that are not </span>
<span id="t1t_196" class="t s4_196">managed surgically, recommendations are based on less panel </span>
<span id="t1u_196" class="t s4_196">consensus: concurrent systemic therapy/RT (category 2B) or induction </span>
<span id="t1v_196" class="t s4_196">chemotherapy followed by chemoradiation or RT (category 3). A neck </span>
<span id="t1w_196" class="t s4_196">dissection may be recommended after treatment with RT and/or systemic </span>
<span id="t1x_196" class="t s4_196">therapy, depending on the clinical response. Since HPV-positive occult </span>
<span id="t1y_196" class="t s4_196">primary is likely located in the tonsil or base of tongue regions, radiation </span>
<span id="t1z_196" class="t s4_196">targets may be limited to these mucosal regions (see </span><span id="t20_196" class="t s6_196">Cancer of the </span>
<span id="t21_196" class="t s6_196">Oropharynx [p16 (HPV)-positive] </span><span id="t22_196" class="t s4_196">in the NCCN Guidelines for Head and </span>
<span id="t23_196" class="t s4_196">Neck Cancers). </span>
<span id="t24_196" class="t s5_196">424 </span>
<span id="t25_196" class="t s4_196">Postoperative therapy among patients with occult primary squamous cell </span>
<span id="t26_196" class="t s4_196">carcinoma is based on the amount of nodal disease and the presence or </span>
<span id="t27_196" class="t s4_196">absence of extranodal extension. For N1 disease without extranodal </span>
<span id="t28_196" class="t s4_196">extension, NCCN Panel Members recommend either: 1) RT that </span>
<span id="t29_196" class="t s4_196">encompasses the target volume; or 2) careful observation with regular </span>
<span id="t2a_196" class="t s7_196">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
